CDK4/6 inhibitor PRT-3645 prolongs survival in glioblastoma and brain-metastatic breast cancers April 26, 2022
CJRS-10671 and CJRS-10672, biotherapeutic candidates with promising antitumor efficacy in vivo April 25, 2022
EGFR-TKI TAS-3351 overcomes T790M and C797S mutations tied to NSCLC treatment resistance April 25, 2022
RSS